Portfolio mapping & regulatory signals

Four families. One workspace. Two ways in.

RegSig is scored regulatory signals joined to real products—and ingredient research that does not wait on a roster. Institutional teams add Compliance (PCR), Controls (GRC), Suppliers (TPRM), and M&A diligence on the same portfolio scope.

  • Portfolio risk concentration
  • Per-product exposure & ownership
  • Scored signals with origin context
IntakeExtractionSignal GenerationPortfolio IntelligenceUnified pipeline from source intake to decision-ready portfolio output

Product offerings

Signal intelligence

Scored, evidence-linked records with jurisdiction tags, horizons, and a clear Act / Prepare / Monitor posture.

Explore signals →

Ingredient intelligence

Research an ingredient against products, signals, and jurisdictions, then draft an Ingredient diligence brief. No portfolio upload required.

Search an ingredient →

Portfolio intelligence

Normalize a roster, map signals to products, and work review rows with owners, urgency, and recommended actions.

View portfolio intelligence →

Governance suite

Institutional modules: Compliance (PCR) — GRC-ready portfolio compliance-risk export; Controls (GRC); Suppliers (TPRM); M&A diligence; admin portal.

Request access →

Platform flow

How the families fit together

Signal intelligence

Ingredient intelligence

Portfolio intelligence

Governance suite

Families

Four families, one workspace

Executives orient on concentration and urgency; operators validate evidence and owners; specialists research a substance without uploading a roster; enterprise programs add Governance exports. Each family reads from the same signal and product records.

Signal intelligence

Ingredient intelligence

Portfolio intelligence

Governance suite

Governance & access

Signals stay tied to evidence; ingredient research needs no roster; portfolio impact stays owned—built for operator review, not opaque alerts.

Start auditing when you are ready, or request institutional access for enterprise onboarding.

  • Human-in-the-loop review stays in operator workflows.
  • Recommendations remain evidence-linked and auditable.
  • Portfolio mapping is role-aware with explicit ownership.